In today’s recent session, 0.55 million shares of the Dare Bioscience Inc (NASDAQ:DARE) have been traded, and its beta is 1.29. Most recently the company’s share price was $0.33, and it changed around $0.02 or 4.50% from the last close, which brings the market valuation of the company to $33.11M. DARE at last check was trading at a discount to its 52-week high of $1.06, offering almost -221.21% off that amount. The share price’s 52-week low was $0.27, which indicates that the recent value has risen by an impressive 18.18% since then. We note from Dare Bioscience Inc’s average daily trading volume that its 3-month average coming to 672.23K.
Dare Bioscience Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended DARE as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Dare Bioscience Inc is expected to report earnings per share of $0.03 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Dare Bioscience Inc (NASDAQ:DARE) trade information
Instantly DARE has been showing a green trend so far today with a performance of 4.50% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently up 6.53% year-to-date, but still up 7.19% over the last five days. On the other hand, Dare Bioscience Inc (NASDAQ:DARE) is -32.11% down in the 30-day period.
Dare Bioscience Inc (DARE) estimates and forecasts
Dare Bioscience Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -5.71 percent over the past six months and at a 37.14% annual growth rate that is well above the industry average of 13.10%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 130.00% in revenue this quarter, and will report an increase of 55.60% in the next quarter. The year-over-year growth rate is expected to be 456.30%, up from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of $13.03 million in revenue for the current quarter. 2 analysts expect Dare Bioscience Inc to make $4.8 million in revenue for the quarter ending Sep 2024. The company’s sales for a year ago were $1 million respectively. Forecasts for the next quarter put sales growth at 380.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 26.02%.
